Understand the source comparison
Best Peptides for Stomach Ulcers: Research Comparison
BPC-157 VEGF upregulation, angiogenesis, fibroblast migration to ulcer site 250–500mcg SC twice daily (investigational human); 10–100mcg/kg in animal studies 48–72 hours for measurable vascular changes; 7–14 days for gross mucosal healing Limited. One pilot st
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, angiogenesis, fibroblast migration to ulcer site
- 250–500mcg SC twice daily (investigational human); 10–100mcg/kg in animal studies
- 48–72 hours for measurable vascular changes; 7–14 days for gross mucosal healing
- Limited. One pilot study (n=22) showed 68% erosion healing at 21 days; no Phase III RCTs
- Most studied for gastric applications; mechanism aligns with known ulcer pathophysiology; lacks large-scale human validation
- TB-500 (Thymosin Beta-4)
- Actin polymerization, epithelial cell migration, inflammation modulation
- 2–5mg SC twice weekly (research protocols)
- 40–55% ulcer diameter reduction within 7 days in rodent models
- None specific to gastric ulcers; some data in wound healing contexts
- Complementary to BPC-157; promotes cell motility; weaker standalone evidence for ulcers specifically
- KPV (Lys-Pro-Val tripeptide)
- MSH (melanocyte-stimulating hormone) mimetic; anti-inflammatory, reduces mast cell degranulation
- 500mcg–1mg oral or SC daily (limited data)
- Demonstrated anti-inflammatory effects in colitis models; gastric ulcer data minimal
- None published
- Theoretical benefit via inflammation reduction; lacks direct tissue repair mechanism like BPC-157
- Cartalax (Ala-Glu-Asp tripeptide)
- Gastric mucosa-specific bioregulator; proposed cytoprotective effects
- 5–10mg oral daily (according to Khavinson Institute protocols)
- Preclinical data primarily from Russian research; limited independent replication
- Observational data only; no controlled trials
- Intriguing mechanism but evidence base is geographically isolated; difficult to evaluate independently